Epithelial-mesenchymal transition (EMT) has pivotal roles during embryonic development and carcinoma progression. Members of the Snai1 family of zinc finger transcription factors are central mediators of EMT and induce EMT in part by directly repressing epithelial markers such as E-cadherin, a gatekeeper of the epithelial phenotype and a suppressor of tumor invasion. However, the molecular mechanism underlying Snai1-mediated transcriptional repression remains incompletely understood. Here we show that Snai1 physically interacts with and recruits the histone demethylase LSD1 (KDM1A) to epithelial gene promoters. LSD1 removes dimethylation of lysine 4 on histone H3 (H3K4m2), a covalent histone modification associated with active chromatin. Importantly, LSD1 is essential for Snai1-mediated transcriptional repression and for maintenance of the silenced state of Snai1 target genes in invasive cancer cells. In the absence of LSD1, Snai1 fails to repress E-cadherin. In cancer cells in which E-cadherin is silenced, depletion of LSD1 results in partial de-repression of epithelial genes and elevated H3K4m2 levels at the E-cadherin promoter. These results underline the critical role of LSD1 in Snai1-dependent transcriptional repression of epithelial markers and suggest that the LSD1 complex could be a potential therapeutic target for prevention of EMT-associated tumor invasion.
Introduction
Epithelial and mesenchymal cells show distinct phenotypic and functional characteristics, yet the two cell types possess substantial plasticity and are interconvertible under certain circumstances (Thiery and Sleeman, 2006; Polyak and Weinberg, 2009 ). Epithelial cells can be reprogrammed into mesenchymal cells, a process known as epithelial-mesenchymal transition (EMT) (Hay, 1995) . During EMT, epithelial cells downregulate epithelial markers, disassemble cell-cell adhesions, lose cell polarity and concomitantly acquire enhanced migratory and invasive properties. EMT is fundamental to embryonic morphogenesis (Yang and Weinberg, 2008; Thiery et al., 2009) . Mesoderm formation and neural crest development represent two prototypic developmental EMT events: During gastrulation, EMT transforms epiblast epithelium into migratory mesenchymal cells that constitute the mesoderm; Through EMT, neural crest progenitor cells delaminate and emigrate extensively from the neural tube to colonize distant embryonic territories. In human cancer, EMT is an important process conducive to tumor invasion and dissemination (Thiery, 2002) . The most prevalent human malignancies are carcinomas, which originate from epithelial cells. The EMT facilitates single carcinoma cells to escape from the rigid structural constraints imposed by intercellular epithelial junctions and to spread to distal sites. Consistently, EMT is frequently detectable at the invasive front of carcinomas where tumor cells show more mesenchymal features.
A hallmark of EMT is the loss of E-cadherin, a defining marker of epithelial cells. E-cadherin regulates the establishment of the adherens junctions during epithelial morphogenesis and is important for the maintenance of tissue architecture (Hay, 1995) . E-cadherin has been considered a suppressor of tumor invasion (Perl et al., 1998) . As E-cadherin is a key caretaker of the epithelial state, understanding the regulation of E-cadherin could help develop anti-invasion cancer therapy by preventing its downregulation or restoring its expression.
The Snai1 family of zinc finger transcription factors Snai1 (also known as Snai1) and Snai2 (also known as Slug) have been identified as direct repressors of E-cadherin transcription and central mediators of EMT (Batlle et al., 2000; Cano et al., 2000; Hajra et al., 2002; Nieto, 2002) . Snai1 and Snai2 critically regulate developmental EMTs such as gastrulation movement and migration of neural crest cells (Nieto, 2002) , and their aberrant expression contributes to the onset of an invasive phenotype in a wide variety of human cancers (Peinado et al., 2007) . Expression levels of the E-cadherin and Snai1 genes are inversely correlated at the leading edge of carcinomas (Franc et al., 2006) .
In eukaryotes, post-translational covalent modifications on histone tails regulate chromatin structure and constitute important regulatory marks demarcating transcriptionally active and inactive chromatin (Jenuwein and Allis, 2001; Kouzarides, 2007; Li et al., 2007) . Generally, transcriptionally active promoters are associated with hyperacetylation of core histones and methylation of histone H3 lysine 4 (H3K4), whereas inactive promoters enrich trimethylated H3K27. Previous studies have shown that Snai1 induces repressive histone modifications at the E-cadherin promoter through recruitment of histone deacetylases (HDACs) and the H3K27 methyltransferase EZH2 (Peinado et al., 2004; Herranz et al., 2008) . However, the significance of H3K4 methylation in Snai1's function remains elusive. In this study, we show that Snai1 physically recruits the lysine-specific demethylase LSD1 (also known as KDM1A and AOF2) to reduce the level of dimethylated H3K4 (H3K4m2) at its target genes, and that LSD1 is required for Snai1-mediated transcriptional repression.
Results

Snai1 directly represses epithelial genes
It was described previously that the forced expression of Snai1 in epithelial cells drives EMT (Nieto, 2002) . We decided to establish a Snai1-dependent EMT system in human mammary epithelial cells. As amino-terminal fusions disrupted Snai1's repressive activity (data not shown), we generated a functional Snai1-Flag construct in which the Flag tag was fused to the carboxyl terminus of Snai1. This Snai1-Flag construct was ectopically introduced into the MCF10A human mammary epithelial cell line and stable transfectants were obtained. The MCF10A cells normally grow as clusters of cells with extensive cell-cell contacts. However, the Snai1-expressing cells became scattered and adopted a fibroblast-like morphology typical of mesenchymal cells. This phenotypic change was associated with loss of expression of epithelial markers Ecadherin and Occludin (Figure 1a ). These observations are indicative of an epithelial to mesenchymal morphological transition in the Snai1-expressing MCF10A cells.
The E-cadherin promoter contains three 'E-box' elements recognized by Snai1 (Figure 1b) (Nieto, 2002) . Two additionally selected epithelial genes claudin-7 (CLDN7) and cytokeratin-8 (KRT8), both of which were reported as direct targets of Snai1 (Ikenouchi et al., 2003; De Craene et al., 2005) , also carry multiple E-boxes at their promoters (Figure 1b) . Using chromatin immunoprecipitation (ChIP) analysis, we investigated whether Snai1 bind to the promoters of these epithelial genes in vivo. Chromatin from control and Snai1-Flag-expressing MCF10A cells was precipitated with control immunoglobulin G and anti-Flag antibodies, and quantitative polymerase chain reaction was performed on the recovered DNA to determine the enrichment of the proximal promoter regions of the epithelial genes as compared with a 5 kb upstream region (À5 kb) of E-cadherin, which serves as a negative control. Occupancy of Snai1 was detected specifically at the promoters of E-cadherin, CLDN7 and KRT8 in the Snai1-Flag cells (Figures 1c and d) .
To confirm that these epithelial genes are indeed inhibited by Snai1, we carried out a similar ChIP assay to monitor the binding of RNA polymerase II at their promoters. Consistent with E-cadherin expression, high levels of RNA polymerase II were detected at the E-cadherin promoter in MCF10A cells. In contrast, this binding was largely abolished in cells expressing Snai1 (Figure 1e ). Similar pattern was observed for the CLDN7 and KRT8 promoters (Figure 1f ). These results suggest that Snai1 directly represses epithelial markers and induces EMT in MCF10A cells.
Snai1 downregulates H3K4m2 levels at epithelial gene promoters Both di-and tri-methylated H3K4 are associated with active transcription (Kouzarides, 2007; Li et al., 2007) .
Having established an EMT model, we applied ChIP analysis to assess potential changes of the active H3K4 methylation marks at the epithelial gene promoters caused by ectopic Snai1 expression. Using an antibody specific for H3K4m2, we detected relatively high levels of H3K4m2 at the promoter of the E-cadherin gene in MCF10A cells, and a significant decrease of this active mark specifically at the promoter region in the Snai1-expressing cells (Figure 2a ). The levels of H3K4m2 in the E-cadherin promoter thus correlate with E-cadherin transcription. Similarly, the CLDN7 and KRT8 promoters also showed reduced H3K4m2 in Snai1-expressing cells (Figure 2b) . Surprisingly, when we performed ChIP assay for the abundance of tri-methylated H3K4 (H3K4m3) at the E-cadherin promoter, there was no difference of this mark between control and Snai1-expressing cells (Figure 2c ). High levels of H3K4m3 were observed at the E-cadherin promoter in both groups of cells, even though E-cadherin is inactive in Snai1-expressing cells. We conclude that expression of Snai1 leads to a specific decrease of H3K4m2 at its target promoters.
Snai1 interacts with LSD1
Decrease in H3K4m2 levels cannot be mediated directly by any known Snai1-associated histone modifying enzymes. H3K4m2 can be demethylated by two types of histone demethylases: LSD1, which belongs to the class of flavin adenine dinucleotide-dependent monoamine oxidases, and members of the JARID1 (KDM5) family of Jumonji (JmjC) domain-containing demethylases (Klose and Zhang, 2007; Shi, 2007) . LSD1 associates with corepressors including HDAC1/2 and CoREST to form a core ternary complex, which is recruited to chromatin and can efficiently bind and modify nucleosomal substrates to repress transcription (Lan et al., 2008) . Unlike JARID1, LSD1 cannot remove trimethylation of H3K4 (Shi et al., 2004) . Given that Snai1 reduces the level of H3K4m2 but not H3K4m3, the LSD1 complex becomes a leading candidate to mediate Snai1's action.
The Snai1 family members share a carboxyl-terminal DNA binding domain composed of zinc finger motifs and a highly conserved amino-terminal repression domain designated SNAG. The SNAG domain extends to about twenty-one amino acids with the first seven amino acids Snai1-mediated repression depends on LSD1 T Lin et al being nearly invariant (Grimes et al., 1996) and it is present in diverse transcriptional repressors including Gfi-1, IA-1, Gsh-1 and Ovo. The SNAG domain has been shown to be essential for repression mediated by Gfi-1 (Grimes et al., 1996) and Snai1 (Batlle et al., 2000) . A recent report has shown that Gfi-1 interacts with the LSD1 co-repressor complex (Saleque et al., 2007) . Given the well-documented transcriptional repressive activities of both the SNAG domain and the LSD1 complex, we hypothesized that the SNAG domain might be sufficient for interaction with the LSD1 complex, and hence, Snai1 might be capable of recruiting the LSD1 complex as well.
We tested this possibility using the in vitro glutathione S-transferase (GST) pull-down assays. As the activity of SNAG is not compatible with fusions to its amino terminus, we specifically fused GST to the carboxyl terminus of the SNAG domain (Figure 3a ). The GST (control) and recombinant SNAG-GST proteins were produced and affinity-purified from bacteria, and were subjected to binding assays with whole cell lysate prepared from mammalian HEK293 cells transfected with Flag-LSD1. Based on western blotting with the anti-Flag antibody, LSD1 was found to be associated with SNAG-GST but not GST (Figure 3b) . Moreover, other components of the LSD1 core complex, the endogenous CoREST and HDAC1 specifically bound to SNAG-GST as well (Figure 3b ). The result suggests that the SNAG domain of Snai1 is sufficient for interaction with the LSD1 complex.
To determine whether such interactions are direct and which subunit of the LSD1 complex is responsible for 
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S-labeled LSD1, CoREST and HDAC1 were produced by in vitro transcription and translation, and subjected to similar GST binding assays. Only LSD1 displayed readily detectable association with SNAG-GST (Figure 3c ), suggesting that LSD1 interacts with the SNAG domain of Snai1 in a direct manner and the other components of the core LSD1 complex (such as HDAC) are recruited to Snai1 indirectly. The specificity of the interaction was further confirmed by lack of binding between LSD1 and the carboxyl-terminal zinc finger motifs of Snai1 (Figure 3c ). Furthermore, a truncated LSD1 mutant that lacks the carboxyl-terminal half of the protein retains the ability to interact with SNAG ( Figure 3d ).
We performed co-immunoprecipitation assays to examine whether Snai1 and LSD1 might form a complex in vivo. HEK293 cells were transiently transfected with a construct encoding Flag-tagged wild-type Snai1 or a P2A mutant form that carries a point mutation in the SNAG domain and fails to repress transcription (Batlle et al., 2000) . Snai1 immunocomplexes were precipitated from cellular extracts with anti-Flag antibodies. The presence of endogenous LSD1 was observed in the immunoprecipitated fraction obtained only from cells expressing wildtype Snai1, but not the P2A mutant (Figure 3e ). This evidence supports the specific association between Snai1 and LSD1 in vivo, and suggests that a functional SNAG domain is essential for this interaction. Finally, the ability of Snai1 to interact with LSD1 was confirmed by immunoprecipitation assays between the endogenous proteins in highly metastatic MDA-MB-231 breast tumor cells (Figure 3f ). Endogenous LSD1 was found to coimmunoprecipitate with endogenous Snai1 in the immunocomplexes obtained with two anti-Snai1 antibodies but not Immunoglobulin G.
Snai1 recruits LSD1 to its target genes Snai1 binds to the epithelial gene promoters and causes a decrease in H3K4m2 levels. Given the direct association between Snai1 and LSD1, LSD1 may be recruited to these promoters by Snai1 where it demethylates H3K4m2. To validate this hypothesis, we examined LSD1 occupancy at the E-cadherin promoter region by ChIP analysis. LSD1 is enriched at the E-cadherin promoter specifically in the Snai1-expressing cells but not in the control MCF10A cells (Figure 4a ). Consistent with this observation, LSD1 is also enriched in the promoters of CLDN7 and KRT8 in Snai1-expressing cells (Figure 4b ). The levels of LSD1 binding inversely correlate with H3K4m2 (compared with Figure 2) .
The invasive MDA-MB-231 breast cancer cells express high levels of Snai1-like factors and are negative for epithelial markers (Hajra et al., 2002) . We asked whether the binding of LSD1 to epithelial gene promoters might be dependent on Snai1 in these cells. 
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We first used short hairpin RNA to deplete Snai1 (Figure 4c) , and then compared LSD1 occupancy at epithelial gene promoters in control and Snai1-knockdown cells. As expected, the binding of LSD1 to the E-cadherin and CLDN7 promoters decreased in the Snai1-depleted cells (Figure 4d ). The remaining binding might be because of the presence of Snai2 in these cells (Hajra et al., 2002) . Taken together, these data suggest that LSD1 is brought to the E-cadherin and other epithelial gene promoters through interaction with Snai1.
LSD1 is essential for Snai1-initiated transcriptional repression As LSD1 is capable of removing the active H3K4m2 mark, it is conceivable that LSD1 may contribute to Snai1-mediated transcriptional repression. Several histone-modifying enzymes, such as HDAC, EZH2 and the arginine methyltransferase PRMT5 (Peinado et al., 2004; Herranz et al., 2008; Hou et al., 2008) , have been identified as co-repressors of Snai1, it was unclear whether LSD1 might have a significant role in Snai1-dependent transcriptional repression.
Snai1 has been reported to function as a potent transcriptional repressor. We speculated that the ability of exogenous Snai1 to repress transcription could be attributed to endogenous LSD1 present in cells. To check whether endogenous LSD1 might contribute to Snai1's repressive activity, we applied short hairpin RNA to substantially deplete endogenous LSD1 in the MCF7 breast cancer epithelial cells (Figure 5a ). Using a luciferase reporter driven by the E-cadherin promoter carrying three E-boxes recognized by Snai1, we found that Snai1 could repress this reporter when transfected into the control MCF7 epithelial cells. However, in MCF7 cells with much reduced LSD1 levels, the Snai1-mediated inhibitory effect on the E-cadherin reporter was essentially eliminated (Figure 5b ). 
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We further studied whether inhibition of endogenous epithelial genes by Snai1 depends on LSD1. Control or LSD1-depleted MCF7 cells were transduced with lentiviral Snai1-IRES-green fluorescent protein , which simultaneously expresses both Snai1 and green fluorescent protein . Green fluorescent protein -positive cells were sorted and purified by flow cytometry, and RNA expression of epithelial genes in these cells was analyzed. Ectopic Snai1 expression potently reduced RNA levels of endogenous E-cadherin, CLDN7, and KRT8 in MCF7 cells (Figure 5c ). In contrast, in cells depleted of LSD1, Snai1's suppressive effect on these genes was significantly diminished (Figure 5c ). Together, these observations suggest that Snai1-initiated inhibition of epithelial genes is dependent on LSD1. Therefore, LSD1 is an essential effector of Snai1-mediated transcriptional repression.
LSD1 is required for maintenance of the silenced state of Snai1 target genes In highly invasive cancer cells such as MDA-MB-231, E-cadherin and other epithelial genes are already silenced. To investigate whether LSD1 is required for maintenance of the silenced state of epithelial genes in these cells, we knocked down endogenous LSD1 with two lentiviral short hairpin RNAs (Figure 6a ). Consequently, upregulation of E-cadherin and CLDN7 mRNA levels was detected in LSD1-deprived cells (Figure 6b ), suggesting that loss of LSD1 leads to de-repression of these genes. However, very much like depletion of the EZH2-containing PRC2 complex (Herranz et al., 2008) , the depletion of LSD1 only resulted in partial activation of E-cadherin. E-cadherin protein could not be detected by western blotting and there was no mesenchymal to epithelial morphological change in LSD1-depleted cells (not shown). It is likely that in addition to LSD1, other repressive mechanisms keep these genes from full activation.
As LSD1 is involved in demethylation of H3K4m2, we examined the H3K4m2 levels at the promoters of E-cadherin and CLDN7. A marked increase in H3K4m2 levels specifically at the E-cadherin and CLDN7 promoters was observed in the LSD1-depleted cells (Figure 6c ), suggesting that LSD1 constantly erases the H3K4m2 mark to prevent its accumulation at the epithelial gene promoters in these cells. These results suggest that an active demethylation process by LSD1 is necessary to reinforce silencing of Snai1 target genes. 
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Discussion
In this study, we have investigated the epigenetic mechanism underlying Snai1-mediated transcriptional repression of epithelial genes. We show that Snai1 directly interacts with the histone demethylase LSD1 and recruits the LSD1 complex to the E-cadherin and other epithelial gene promoters, resulting in downregulation of the active H3K4m2 mark and promoter activity. As depletion of LSD1 substantially impairs Snai1's ability to repress its targets, LSD1 serves as an essential effector of Snai1-dependent transcriptional repression of epithelial genes. Mouse embryos deficient for LSD1 die at gastrulation (Wang et al., 2007 (Wang et al., , 2009 . As Snai1 and Snai2 have critical roles in EMT events during mesoderm and neural crest development, it is interesting to examine whether LSD1 mutant embryos have the corresponding defects. Recent studies show that LSD1 is highly expressed in clinically advanced breast tumors and in poorly differentiated neuroblastomas (Schulte et al., 2009; Lim et al., 2010) .
Together with the prominent role of Snai1 family members in initiation of EMT and tumor invasion (Peinado et al., 2007) , targeting the enzymatic components of the LSD1 complex with pharmacological agents may offer a new avenue to thwart tumor progression and dissemination. While this study highlights the significance of an epigenetic silencing mechanism in Snai1's function, the exact mechanism underlying Snai1-dependent transcriptional repression is complex. In addition to the LSD1 complex, Snai1 has been reported to directly or indirectly associate with repressor complexes containing HDAC, PRC2 and Ajuba-PRMT5, through its SNAG domain (Peinado et al., 2004; Herranz et al., 2008; Hou et al., 2008) . All these complexes are somewhat essential for Snai1's action. Although we show that the Snai1-LSD1 interaction is probably direct, it remains to be determined whether all these components are in the same complex, or they interact with Snai1 independently. As a consequence, Snai1 leaves multiple repressive histone modifications at its target genes, including histone hypoacetylation, decreased H3K4m2, and increased H3K27m3. Because the H3K4m3 mark is not a substrate of LSD1 and remains intact in Snai1-expressing cells (Figure 2c ), Snai1 apparently induces a 'bivalent' histone modification pattern with co-existence of both H3K4m3 and H3K27m3. Promoters with bivalent histone modifications are inactive but are poised for activation (Bernstein et al., 2006) . This implies that Snai1-repressed epithelial genes are primed for re-activation, which is consistent with the reversibility of EMT (Thiery and Sleeman, 2006) .
Materials and methods
Plasmids and antibodies
Full-length human Snai1 cDNA was PCR amplified and cloned into pcDNA3 (Invitrogen, Carlsbad, CA, USA) with a Flag epitope tag at its carboxyl end. The Snai1-P2A mutant was generated using the QuickChange II site-directed mutagenesis Kit (Stratagene, La Jolla, CA, USA). Lentiviral expression vector for Snai1-IRES-GFP was made in pCSCGW2. The expression plasmids for SNAG-GST and GST-ZF were based on pGEX-KG. The human E-cadherin promoter was polymerase chain reaction amplified and cloned into the pGL3 vector for luciferase reporter assays. The short hairpin RNA constructs specifically targeting human LSD1 were in the retroviral pSuper and lentiviral pGIPZ (OpenBiosystems, Huntsville, AL, USA) vectors.
The following antibodies were used in this study: antiH3K4m2, anti-H3K4m3, anti-Snai1, anti-LSD1 and anti-Ecadherin (Cell Signaling, Danvers, MA, USA); anti-LSD1, anti-RNA polymerase II (Millipore, Billerica, MA, USA); anti-Snai1 (Santa Cruz, Santa Cruz, CA, USA); anti-Flag, anti-Occludin and anti-Tubulin (Sigma, St Louis, MO, USA).
Cell culture, transfection, infection, luciferase assay and RT-PCR The human cell lines HEK293, MCF7 and MDA-MB-231 were grown in regular Dulbecco's modified Eagle medium (Cellgro, Manassas, VA, USA) supplemented with 10% bovine calf serum (BCS). MCF10A cells were cultured in Dulbecco's modified Eagle medium/F12 medium (Cellgro) supplemented with 5% horse serum (Sigma), 20ng/ml epidermal growth factor (EGF, Sigma), 10 mg/ml insulin (Sigma) 0.5 mg/ml hydrocortisone (Sigma).
To establish a Snai1-expressing stable cell line, MCF10A cells were transfected with the Snai1-Flag expression plasmid and stable transfectants were picked and verified for Snai1 expression by western blotting. All the transfections were done using Turbofect transfection reagent (Fermentas, Glen Burnie, MD, USA) according to the manufacturer's instructions.
For the reporter assay, MCF7 cells were transfected with the E-cadherin promoter luciferase reporter and SV40-driven renilla reporter plasmids, and harvested for luciferase assays 48 h later. Luciferase activities were determined using the dual luciferase reporter assay system (Promega, Madison, WI, USA). Renilla luciferase was used as a reference to normalize transfection efficiencies in all experiments. All values are means ± s.d. from three independent experiments.
For RNA isolation and RT-PCR assays, Snai1-IRES-GFP expression lentivirus was used to infect control or LSD1-depleted MCF7 cells. The transduced cells were sorted by flow cytometry based on the GFP signal. Total RNA from cells was extracted with TRIzol reagent (Invitrogen) following the manufacturer's instruction, and Complementary DNA was synthesized using moloney murine leukemia virus (M-MuLV) reverse transcriptase with random primers. The expression levels of selected genes were determined by quantitative PCR.
GST pull-down, co-immunoprecipitation and ChIP Both GST pull-down and co-immunoprecipitation assays were performed as previously described (Ao et al., 2008) .
For ChIP assay, cells were cross-linked with 1% formaldehyde for 10 min. The reaction was stopped by the addition of glycine. Cross-linked cells were washed in 1X phosphatebuffered saline and collected. Cell pellets were washed in washing buffer (0.25% Triton X-100, 10 mm ethylene diamine tetraacetic acid (EDTA), 0.5 mm ethylene glycol tetraacetic acid (EGTA), 10 mm Tris pH 8.0), resuspended in sonication buffer (1 mm EDTA, 0.5 mm EGTA and 10 mm Tris pH 8.0), mixed with glass beads, and subjected to sonication. The sonicated samples were diluted in ChIP buffer (0.01% sodium dodecyl sulfate 1.0% Triton X-100, 1.0 mm EDTA, 20 mm Tris pH 8.1, 150 mm NaCl) and incubated with specific Snai1-mediated repression depends on LSD1 T Lin et al antibodies and protein A slurry (Invitrogen). The immunoprecipitates were subjected to a series of washing steps to remove non-specific binding. After reverse-cross-linking, the DNA samples were purified and then analyzed by real-timequantitative polymerase chain reaction. Final results represent percentage of input chromatin and error bars indicate s.d. from triplicate experiments.
